Clinical Trials Browser

Phase 2 × OTHER × HER2-negative Metastatic Breast Cancer × Clear all

NCT04720729 2025-06-22

MONDRIAN

Phase 2 Terminated

HER2-negative Metastatic Breast Cancer

NCT06533722 2025-06-10

Adaptive Therapy for Post-Second-Line Advanced Breast Cancer

Phase 2 Completed

HER2-negative Metastatic Breast Cancer